Literature DB >> 1622179

Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.

T J Lubowski1, C Nightingale, K Sweeney, R Quintiliani, J Zhi.   

Abstract

The penetration of multiple-dose concentrations of oral fleroxacin (400 mg every 24 h) and ciprofloxacin (500 mg every 12 h) into skin blister fluid in 12 healthy volunteers was determined in a randomized crossover study. Serum, blister fluid, and paper disk samples were analyzed by large-plate microbiologic assay. The mean areas under the concentration-time curve (AUC) for serum were 88.6 and 18.2 micrograms.h/ml/70 kg for fleroxacin and ciprofloxacin, respectively. The mean AUC for blister fluid and paper disks were 71.2 and 15.0 micrograms.h/ml/70 kg and 77.8 and 15.4 micrograms.h/ml/70 kg for fleroxacin and ciprofloxacin, respectively. Calculated penetration into interstitial fluid ranged from 74 to 92% for fleroxacin and 56 to 96% for ciprofloxacin; penetration was calculated by using the ratio of maximum drug concentration or AUC in blister fluid and paper disks to maximum drug concentration or AUC in serum. There was no significant difference between fleroxacin and ciprofloxacin in the percent penetration into skin blister fluid.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1622179      PMCID: PMC190573          DOI: 10.1128/AAC.36.3.651

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.

Authors:  R Wise; B Kirkpatrick; J Ashby; D J Griggs
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

2.  Single and multiple dose pharmacokinetics of fleroxacin.

Authors:  E Weidekamm; R Portmann; C Partos; D Dell
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

3.  Meropenem pharmacokinetics and penetration into an inflammatory exudate.

Authors:  R Wise; M Logan; M Cooper; J P Ashby; J M Andrews
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

4.  Pharmacokinetics and tissue penetration of ciprofloxacin.

Authors:  B Crump; R Wise; J Dent
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

5.  Suction skin blister, skin window, and skin chamber techniques to determine extravascular passage of cefotaxime in humans.

Authors:  R F Frongillo; L Galuppo; A Moretti
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

6.  Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers.

Authors:  R E Polk; D P Healy; J Sahai; L Drwal; E Racht
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

7.  Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.

Authors:  A C Panneton; M G Bergeron; M LeBel
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

8.  Transfer of penicillin G and ampicillin into human skin blisters induced by suction.

Authors:  A Schreiner; K B Hellum; A Digranes; I Bergman
Journal:  Scand J Infect Dis Suppl       Date:  1978

Review 9.  Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions.

Authors:  M LeBel
Journal:  Pharmacotherapy       Date:  1988       Impact factor: 4.705

  9 in total
  3 in total

1.  Penetration of ciprofloxacin and fleroxacin into biliary tract.

Authors:  C E Edmiston; E C Suarez; A P Walker; M P Demeure; C T Frantzides; W J Schulte; S D Wilson
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

2.  Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.

Authors:  J Schrenzel; F Cerruti; M Herrmann; T Leemann; E Weidekamm; R Portmann; B Hirschel; D P Lew
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 3.  Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.

Authors:  J A Balfour; P A Todd; D H Peters
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.